Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Nature Pharmaceutical (also known as Jiangxi Universe Pharmaceuticals) is a Chinese pharmaceutical company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivatives (TCMD) and traditional Chinese medicine pieces (TCMP). Founded in 1998 and headquartered in Ji'an, Jiangxi, the company primarily targets chronic health conditions in the elderly, such as physical weakness, joint pain, and cardiovascular wellness, as well as cold and flu remedies. Its product portfolio includes proprietary formulations like Guben Yanling Pills, Shenrong Weisheng Pills, and various medicinal liquors. The company operates as the primary operating subsidiary of the Nasdaq-listed holding company Universe Pharmaceuticals INC (UPC).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Nature Pharmaceutical.